Publication | Open Access
Stereotactic body radiotherapy for early stage non-small cell lung cancer in patients with subclinical interstitial lung disease
19
Citations
20
References
2020
Year
Subclinical ILD was not a significant factor for RILI or PFS in early stage NSCLC patients receiving SBRT; however, patients with subclinical ILD receiving SBRT may experience uncommon extensive RILI.
| Year | Citations | |
|---|---|---|
Page 1
Page 1